Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd.

Wednesday, February 28, 2018

Valeant Pharmaceuticals International Inc today announced its subsidiary has entered into an exclusive license agreement with Kaken Pharmaceutical Co Ltd Kaken to develop and commercialize products containing a new chemical entity KP which is an inve...

Chugai's HEMLIBRA® Approved by European Commission in Hemophilia A with Inhibitors

Wednesday, February 28, 2018

Chugai Pharmaceutical Co Ltd announced that Roche has received regulatory approval from the European Commission for HEMLIBRA emicizumab for routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors Following...

Xencor Signs Four Commercial License Agreements with Selexis SA

Tuesday, February 27, 2018

Selexis SA a pioneering life sciences company and a global leader in mammalian cell line generation technology today announced that it has signed four commercial license agreements CLAs with Xencor Inc NASDAQ XNCR a clinicalstage biopharmaceutical co...

Lantern Pharma Joins Genomics England to Advance Their Precision Oncology Platform

Tuesday, February 27, 2018

Genomics England and Lantern Pharma a clinical stage pharma company specializing in precision oncology using artificial intelligence announced today that Lantern will join Genomics Englands Discovery Forum industry partnership The partnership aims to...

Kazia Receives FDA Orphan Designation for GDC-0084

Monday, February 26, 2018

Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that the United States Food and Drug Administration FDA has granted Orphan Drug Designation ODD to Kazias investigational new drug GDC for the treat...

Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing

Saturday, February 24, 2018

Mallinckrodt plc a leading global specialty pharmaceutical company today announced the US Food and Drug Administration FDA has accepted its New Drug Application NDA seeking approval of its recently acquired developmental product stannsoporfin If appr...

Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration

Friday, February 23, 2018

Kite a Gilead Company and Sangamo Therapeutics Inc today announced the companies have entered into a worldwide collaboration using Sangamos zinc finger nuclease ZFN technology platform for the development of nextgeneration ex vivo cell therapies in o...

MYR Pharma Announces Completion of Active Treatment Phase in MYR 203 Clinical Trial of Myrcludex B

Friday, February 23, 2018

MYR Pharma GmbH today announced the completion of the weeklong active treatment phase in MYR clinical trial a part of Phase b program investigating Myrcludex B in combination with pegylated interferon PEG INF in chronic hepatitis Delta HDV infection...

Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline

Thursday, February 22, 2018

Merck known as MSD outside the United States and Canada and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that Merck through a subsidiary will acquire Viralytics an Australian publicly t...

ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

Thursday, February 22, 2018

Dedicated to creating technologies and tools to improve peoples lives ATUM today announced a patent licensing agreement giving Just Biotherapeutics access to the companys LeapIn cell line development tools We love everything about Justs mission an...